Recent Articles from Business Wire

Sensata Foundation Awards More Than $600,000 to 49 US Nonprofits for STEM Education and Community Priorities
Sensata Foundation, the philanthropic arm of Sensata Technologies, has awarded $624,100 in annual grants to 49 charitable organizations across the US, including 12 new grantees. The grants help advance the Foundation’s vision to empower the next generation of engineers and support communities where Sensata employees live and work.
By Sensata Technologies · Via Business Wire · November 4, 2026
MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd (“Teva Australia”) to deploy ReefIQ™, MindWalk’s HYFT®-powered biological context layer with specified LensAI™ analytical capabilities, in support of a defined scope of antibody-discovery work. Teva Australia will use the AI capabilities to support discovery decisions based on generated predictions and accelerate antibody design optimization. MindWalk has been collaborating with Teva Australia since 2018.
By MindWalk Holdings Corp. · Via Business Wire · November 4, 2026
ImmunityBio Announces First Patients in Europe Treated with ANKTIVA® Plus BCG for BCG-unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the first patients in Europe received treatment with ANKTIVA® (nogapendekin alfa inbakicept) in combination with Bacillus Calmette-Guérin (BCG) for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. The treatments were administered in Germany and Austria, marking an important step in expanding patient access to ANKTIVA across Europe.
By ImmunityBio, Inc. · Via Business Wire · November 4, 2026
Stem Reschedules Third Quarter 2026 Earnings Results Conference Call to Monday, November 16, 2026
Stem, Inc. (“Stem,” “we,” or the “Company”) (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced that it has rescheduled the release of its third quarter 2026 financial results and conference call to Monday, November 16, 2026, from November 5, 2026, for scheduling and logistical reasons. The conference call is scheduled to begin at 5:00 p.m. Eastern Time on November 16, 2026. A press release regarding the results will be issued at approximately 4:05 p.m. Eastern Time.
By Stem, Inc. · Via Business Wire · November 4, 2026
SmartRent Reports Third Quarter 2026 Financial Results
SmartRent, Inc. (NYSE: SMRT) (“SmartRent” or the “Company”), a market-leading building intelligence provider delivering innovative data, technology and workflow solutions for the rental housing industry, today reported financial results for the three months ended September 30, 2026.
By SmartRent · Via Business Wire · November 4, 2026
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.32 per share, to be paid on December 15, 2026, to all shareholders of record of UNH common stock as of the close of business December 7, 2026.
By UnitedHealth Group · Via Business Wire · November 4, 2026
Ryan’s Internship Program Named One of the 150 Best Internships by Vault®
Ryan, a leading global tax services and software provider, is pleased to announce its internship program has been named to the Vault® 150 Best Internships list for 2027. The recognition reflects the Firm’s continued commitment to providing students with hands-on experience, mentorship, and opportunities to build a strong foundation for their careers.
By Ryan · Via Business Wire · November 4, 2026
Hadron Energy to Report Third Quarter 2026 Financial Results and Host Conference Call on November 9, 2026
Hadron Energy, Inc. (Nasdaq: HDRN) (“Hadron” or the “Company”), an advanced nuclear technology company developing the 10-megawatt electric (10MWe) Halo Micro-Modular Reactor (MMR), today announced that it will report financial results for the third quarter ended September 30, 2026 after market close on Monday, November 9, 2026, and will host a conference call beginning at 4:30 PM ET. Participants may pre-register at the link below.
By Hadron Energy, Inc. · Via Business Wire · November 4, 2026
SANS Institute Veteran Rob T. Lee Joins Dragos as Chief AI Officer
Dragos, Inc., the global leader in xOT cybersecurity, today announced that Rob T. Lee has joined the company as its first Chief AI Officer. Rob T. Lee joins from SANS Institute, where he spent more than 25 years developing and teaching courses for security practitioners and most recently led the institute’s AI work. At Dragos, he will focus on helping industrial and critical infrastructure organizations understand and manage the impact of AI on their operations. He reports to Dragos Founder, Chairman, and CEO Robert M. Lee.
By Dragos, Inc. · Via Business Wire · November 4, 2026
Freeport Announces Plans to Boost U.S. Copper & Molybdenum Production
Freeport (NYSE:FCX) announced today that its Board of Directors approved a $4.5 billion expansion and modernization program for its wholly owned Bagdad copper and molybdenum operation in northwest Arizona.
By Freeport-McMoRan Inc. · Via Business Wire · November 4, 2026
DHI Mortgage, LoanDepot, Paramount Residential Mortgage Group and CMG Financial Join Growing Roster of FICO® Preferred Program Lenders
FICO (NYSE: FICO), global analytics software leader, today announced that DHI Mortgage, LoanDepot, Paramount Residential Mortgage Group and CMG Financial have enrolled in the FICO® Preferred Program and will continue to pull FICO® Scores across their mortgage lending operations. Their participation adds to growing momentum behind the program and underscores the mortgage industry’s continued demand for low-cost credit score options that lower loan execution costs for consumers.
By FICO · Via Business Wire · November 4, 2026
PiLogic Receives SpaceWERX's AIS Challenge Phase I Award; Supports Two Additional Awardee Teams
PiLogic, the company building explainable artificial intelligence for complex space systems, has won a prime Phase I award under SpaceWERX's Adaptive and Intelligent Space (AIS) Challenge, a U.S. Space Force STTR program aimed at making satellite operations more autonomous and resilient. Starcloud is subcontracting to PiLogic on the effort, hosting the demonstration on its ground-based FlatSat and, later, on-orbit aboard Starcloud-1.
By PiLogic · Via Business Wire · November 4, 2026
Together AI Launches Together Compiler for Continual Optimization of Open Source AI Models
Together AI, the AI-native cloud, today announced Together Compiler, which uses teams of AI agents to rewrite the GPU code behind the models it serves. New open source models now get faster overnight instead of in weeks, with no additional work from customers. Together Compiler is the first step towards recursive self-improving inference and serves trillions of tokens per day.
By Together AI · Via Business Wire · November 4, 2026
Astrolab Unveils LUMIS Power and Communications Node for Lunar Operations
Astrolab today introduced the Lunar Utility Module for Industrial Services (LUMIS), a lunar power, communications and data node designed to provide energy, connectivity, and data services to customers operating on the Moon. The announcement marks an expansion of Astrolab’s business beyond rovers and introduces its new positioning as “The Lunar Operations Company,” bringing together the surface mobility, power and connectivity needed for sustained human and robotic operations.
By Astrolab · Via Business Wire · November 4, 2026
Avnet Reports First Quarter 2027 Financial Results
Avnet, Inc. (Nasdaq: AVT) today announced results for its first quarter ended October 3, 2026.
By Avnet · Via Business Wire · November 4, 2026
Alnylam to Webcast Presentation at the Jefferies Global Healthcare Conference
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 10:00 a.m. GMT (5:00 a.m. ET) in London.
By Alnylam Pharmaceuticals, Inc. · Via Business Wire · November 4, 2026
Optimum To Report Q3 2026 Financial Results on November 6, 2026 through Form 10-Q
Optimum Communications (NYSE: OPTU) today announced that it expects to report its financial and operating results for the third quarter ended September 30, 2026, through its Quarterly Report on Form 10-Q, which is expected to be filed with the Securities and Exchange Commission ("SEC") on Friday, November 6, 2026.
By Optimum Communications, Inc. · Via Business Wire · November 4, 2026
BDO Research: AI Moves Into High-Stakes Financial Judgments, Raising the Bar for Governance
BDO’s third annual Audit Innovation Survey, released today, finds that AI has moved beyond operational and analytical tasks and into the financial estimates and judgments that external auditors review. The research also finds that confidence in AI is outpacing the governance, documentation, and evidence needed to fully support AI-informed results.
By BDO · Via Business Wire · November 4, 2026
MARA Forensics Debuts Targeted Pro: Remote Mobile Collection That Takes Only What the Matter Needs
Custodians do not want their entire phone imaged, with every photo, health record and private conversation swept into a legal matter. Yet the relevant evidence is often a few conversations, and collecting it has usually meant imaging the whole device.
By MARA Forensics · Via Business Wire · November 4, 2026
InTest Corporation to Attend Upcoming Investor Conferences
InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets that include semiconductor (“semi”), automotive/EV, defense/aerospace, industrial, life sciences, and safety/security, today announced its participation in the following upcoming investor conferences:
By InTest Corporation · Via Business Wire · November 4, 2026
MariaDB Launches into the Agentic Era with an Agent-Ready Platform and a Bold New Brand
MariaDB plc, the Unified Open Database Platform for the Agentic Enterprise, today announced MariaDB Enterprise Platform 2027, a release that delivers 56% higher peak throughput¹, stronger resilience for multi-region deployments and faster ways to build and run AI agents. What began as an open source operational database now spans mission-critical transactions, real-time analytics, in-memory speed, AI tooling and multi-region scale on one unified platform. The new brand identity unveiled alongside it shows where the company is headed, powering the AI-driven enterprise with the world’s most trusted database platform.
By MariaDB · Via Business Wire · November 4, 2026
Vantage Appoints Dale Drew as Chief Information Security Officer
Vantage, a leading global provider of digital infrastructure, today announced the appointment of Dale Drew as chief information security officer. Reporting to Emily Friedberg, chief information officer, Drew will lead Vantage’s global information security organization across North America, EMEA and Asia Pacific, defining and executing the enterprise-wide security strategy, strengthening the protection of critical assets, supporting regulatory compliance and managing cyber risk.
By Vantage · Via Business Wire · November 4, 2026
Kimia Therapeutics Advances Oncology Asset to Clinical Stage in Collaboration with CStone Pharmaceuticals
Kimia Therapeutics, Inc. (Kimia), a biotechnology company advancing small-molecule medicines in oncology and immunology with its integrated ATLAS discovery platform, today announced a clinical collaboration agreement with CStone Pharmaceuticals (CStone, HKEX: 2616). Under the agreement, CStone will advance Kimia’s lead oncology asset, KT-721, a novel small-molecule therapy targeting pathways critical for tumor cell survival, into Phase 1 clinical development. The collaboration marks Kimia’s transition to a clinical-stage company, with first patient dosing expected in early 2027.
By Kimia Therapeutics, Inc. · Via Business Wire · November 4, 2026
Circle Pharma Announces Participation in November Investor Conferences
Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced management will participate in two upcoming investor conferences in November:
By Circle Pharma, Inc. · Via Business Wire · November 4, 2026
Brown-Forman Second Quarter Earnings Release and Conference Call Scheduled for December 3, 2026
Brown-Forman Corporation (NYSE: BFA, BFB) will release its second quarter and first half of fiscal year 2027 financial results on December 3, 2026, by 8:00 a.m. EST, followed by a conference call to discuss the results at 10:00 a.m. EST.
By Brown-Forman Corporation · Via Business Wire · November 4, 2026
Evident Vascular Receives FDA Clearance for High-Fidelity AI Powered IVUS Imaging Platform
Evident Vascular, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident Vascular® Guidance System and Evident® peripheral imaging catheters. The Evident Vascular Guidance System is intended for ultrasound examination of intravascular pathology during peripheral vascular interventions.
By Evident Vascular, Inc. · Via Business Wire · November 4, 2026
Atlanta Braves Holdings Reports Third Quarter 2026 Financial Results
Atlanta Braves Holdings, Inc. (“ABH”) (Nasdaq: BATRA, BATRK) today reported results for its third quarter ended September 30, 2026.
By Atlanta Braves Holdings, Inc. · Via Business Wire · November 4, 2026
AdvanCell Strengthens Leadership with Appointment of Andy Porter as Chief People Officer and Martin Huber, M.D., to its Board of Directors
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Andy Porter as Chief People Officer and Martin (Marty) Huber, M.D., to its Board of Directors. These appointments strengthen AdvanCell's executive leadership team and Board as the Company advances its clinical pipeline, prepares for late-stage development and support its next phase of growth.
By AdvanCell · Via Business Wire · November 4, 2026
BitGo Launches Global Markets to Broaden Institutional Offerings, Names Pete Janney to Lead the Business
BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo” or “Company”), the digital asset infrastructure company, today announced the launch of BitGo Global Markets, its institutional trading and financial solutions business bringing together global liquidity, execution, financing, derivatives, and settlement capabilities.
By BitGo Holdings, Inc. · Via Business Wire · November 4, 2026
FORE Biotherapeutics to Present New Clinical and Preclinical Plixorafenib Data at Upcoming Oncology Medical Meetings
FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced two abstracts that have been selected for presentation at two prestigious oncology medical meetings. The first is an oral presentation highlighting long-term efficacy and safety data from a Phase 1/2a study evaluating plixorafenib in patients with BRAF V600 primary CNS tumors and will be presented at the upcoming Society for Neuro-Oncology (SNO) 2026 Annual Meeting taking place in Philadelphia November 12-15, 2026. The second is a poster presentation featuring new preclinical data supporting plixorafenib’s unique mechanism of action and its potential as a future treatment for BRAF-altered colorectal cancer (CRC) and will be presented at the 38th EORTC-NCI-AACR Symposium (ENA 2026) taking place in Barcelona November 18-20, 2026.
By FORE Biotherapeutics · Via Business Wire · November 4, 2026
Crescent Capital Group Prices $406.9 Million Collateralized Loan Obligation
Crescent Capital Group LP, one of the leading alternative credit investment firms, today announced the pricing of Atlas Senior Loan Fund XXVIII (“Atlas 28”), a $406.9 million new-issue collateralized loan obligation (“CLO”) on October 29, 2026. This transaction represents Crescent’s second new-issue CLO of 2026 and the fourth issued through its CLO Equity Fund II, which closed in August. The transaction attracted 20 distinct investors, and will invest primarily in U.S. senior secured term loans as well as select senior secured corporate bonds.
By Crescent Capital Group LP · Via Business Wire · November 4, 2026
Incyte to Present at Upcoming Investor Conferences
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of November:
By Incyte · Via Business Wire · November 4, 2026
CrowdStrike Announces Date of Fiscal Third Quarter 2027 Financial Results Conference Call
CrowdStrike Holdings, Inc. (Nasdaq: CRWD), today announced that it will release financial results for its fiscal third quarter 2027 ended October 31, 2026 after the U.S. market close on Tuesday, December 1, 2026. CrowdStrike will host a conference call that day at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) to discuss the results.
By CrowdStrike Holdings, Inc. · Via Business Wire · November 4, 2026
Marqeta to Participate in Upcoming Investor Conferences
Marqeta, Inc. (NASDAQ: MQ), the modern card issuing platform, today announced that it will participate in the following investor events:
By Marqeta · Via Business Wire · November 4, 2026
Bayer and America’s Grow-a-Row Continue Partnership to Fight Food Insecurity
In 2026, Bayer and America’s Grow-a-Row continued their longstanding partnership to combat food insecurity and expand access to fresh, nutritious produce for communities across the United States.
By Bayer · Via Business Wire · November 4, 2026
BODi Launches Limited-Edition Cinnamon Roll Shakeology with 0g Added Sugar, Delivering Serious Nutrition and Supporting Gut Health in a Dessert-Inspired Flavor
BODi (NASDAQ: BODI), the proactive wellness company delivering nutrition, supplements and proven fitness programs that help people take control of their health inside and out, today announced the launch of Cinnamon Roll Whey Shakeology with 0g Added Sugar. Designed to deliver serious nutrition and support gut health in a delicious dessert-like experience, the new flavor combines the decadent taste of a freshly baked cinnamon roll with Shakeology’s comprehensive protein and superfood nutrition formulation, offering a satisfying way to support everyday wellness with a flavor that is growing in popularity. Available for a limited time while supplies last, Cinnamon Roll Whey Shakeology gives everyone a new way to get the daily health benefits of this billion serving seller in a craveable, dessert-inspired flavor.
By BODi · Via Business Wire · November 4, 2026
Bluetooth® High Data Throughput Opens a New Chapter in Wireless Performance
The Bluetooth Special Interest Group (SIG), the trade association that oversees Bluetooth® technology, today announced the adoption of Bluetooth® High Data Throughput (HDT), the next major milestone in the evolution of Bluetooth technology, introducing faster data transfer, increased capacity, better energy efficiency, and enhanced reliability. By significantly expanding the Bluetooth performance envelope, Bluetooth HDT establishes the foundation for the next generation of wireless experiences and continued innovation across the global Bluetooth ecosystem.
By Bluetooth Special Interest Group · Via Business Wire · November 4, 2026
Citrix Advances Secure AI Adoption With New Governance Capabilities, Agentic Workspaces and Flexible Consumption Options
Citrix, a Cloud Software Group company, today announced new capabilities across Citrix SecurSpaces™, Citrix SecurAccess™ and Citrix® Platform Flex designed to help organizations securely deploy AI agents, govern AI-powered work and scale adoption across the enterprise. These updates include an expansion of Citrix SecurSpaces to a wider set of personas; new AI governance capabilities for Citrix SecurAccess; and a new credit-based model offering Citrix customers a more flexible way to consume Citrix solutions and services.
By Citrix · Via Business Wire · November 4, 2026
Namibia Breweries Limited, WWF Namibia and Global Water Challenge Sign N$13 Million Agreement to Strengthen Swakop River Basin Water Security
Namibia Breweries Limited (NBL), World Wildlife Fund (WWF Namibia) and the Global Water Challenge (GWC) today announced the signing of a Memorandum of Agreement (MoA) to implement the Swakop Basin Collective Action Project, also known as the NBL Water Balancing Project. The five-year initiative brings together government, civil society and the private sector to address shared water challenges and strengthen water security and climate resilience in the Swakop River Basin.
By Global Water Challenge · Via Business Wire · November 4, 2026
Joby Expands Autonomous Flight Contracts with U.S. Air Force to Nearly $37 Million Following Record Coast-to-Coast Tour
Joby Aviation, Inc. (NYSE: JOBY) today announced that the U.S. Air Force has awarded additional funding to accelerate Joby’s autonomous flight technology, bringing the Air Force’s total commitment to nearly $37 million and raising the ceiling on Joby’s operational testing contract to $50 million. Awarded through AFWERX, the innovation arm of the U.S. Air Force, the funding supports continued development of Joby’s autonomy software and expanded operational testing in the Pacific, as the Air Force moves toward sustained autonomous logistics operations.
By Joby Aviation, Inc. · Via Business Wire · November 4, 2026
Enveric Biosciences Reports Differentiated Brain Activity Profile for EB-003 in Preclinical qEEG Study
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced results from a quantitative electroencephalography (qEEG) study of its lead candidate, EB-003, in mice. The study demonstrated modulation of brain activity in prefrontal and parietal regions of the cortex, providing functional evidence of central nervous system penetration and revealing a neurophysiological profile differentiated from dimethyltryptamine (DMT), a classic hallucinogenic psychedelic.
By Enveric Biosciences · Via Business Wire · November 4, 2026
Foodtastic Corrects the Record Regarding MTY Food Group’s Misleading Comments
Foodtastic Inc. (“Foodtastic”), a Canadian restaurant franchisor, today issued the following statement responding to the misleading press release from MTY Food Group Inc. (“MTY” or the “Company”) (TSX: MTY) related to Foodtastic’s proposal to acquire all outstanding shares of MTY for $43 per share in cash (the “Proposed Transaction”):
By Foodtastic · Via Business Wire · November 4, 2026
U.S. Food Insecurity Jumps Most in Over 4 Years: Up 11 Points for Middle-Income Households, and Nearly Doubles for Seniors, dunnhumby Finds
One in three U.S. consumers (34%) reported they had skipped meals or cut meal sizes in the past year for financial reasons, up 7 percentage points since December and the largest increase between surveys in the four-year history of the dunnhumby Consumer Trends Tracker (CTT). Thirty-one percent of middle-income households earning $50,000 - $100,000, reported not having enough to eat compared with 19% in December, the sharpest rise in the 13th wave of the CTT. Consumers 65 and older saw the second-largest increase, nearly doubling to 17%.
By dunnhumby · Via Business Wire · November 4, 2026
Immunocan Achieves Megabase-Scale Human Immunoglobulin Gene Replacement in Rabbits, Creating a Cross-Species Data Engine for AI-Driven Antibody Discovery
Shanghai Immunocan Biotech Co., Ltd. (“Immunocan”) today announced the successful in situ replacement of megabase (Mb)-scale human immunoglobulin (Ig) gene segments at endogenous Ig loci in rabbits using its proprietary MASIRT® (Massive-fragment Across Species In situ Replacement Technology) platform.
SS&C Announces Proposed Private Placement of $1.0 Billion of Convertible Senior Notes Due 2031
SS&C Technologies Holdings, Inc. (the “Company” or “SS&C”) (NASDAQ: SSNC), a global provider of investment, financial and healthcare technology and technology-enabled services, today announced that it intends to offer, subject to market conditions and other factors, $1.0 billion aggregate principal amount of Convertible Senior Notes due 2031 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). SS&C also intends to grant the initial purchasers of the notes an option to purchase, for settlement during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $150.0 million aggregate principal amount of the notes.
By SS&C · Via Business Wire · November 4, 2026
FIS Announces Chief Financial Officer Transition; Names Alexandra Brooks Interim CFO
FIS® (NYSE: FIS), a global leader in financial technology, today announced that James Kehoe will step down as Chief Financial Officer, effective November 5, 2026. Kehoe will serve as a non-executive senior advisor through March 2027 to support an orderly transition of responsibilities. Kehoe will also participate in the company’s third quarter 2026 earnings call today as planned.
FIS Reports Third Quarter 2026 Results
FIS® (NYSE: FIS), a global leader in financial technology, today reported its third quarter 2026 results.
XPEL Reports Revenue of $137.8 million; Revenue Growth of 9.9% in Third Quarter 2026
XPEL, Inc. (Nasdaq: XPEL) (the "Company"), a global provider of protective films and coatings, announced consolidated results1 for the third quarter and nine months ended September 30, 2026.
By XPEL · Via Business Wire · November 4, 2026
lululemon athletica inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LULU
The DJS Law Group reminds investors of a class action lawsuit against lululemon athletica inc. (“Lululemon” or “the Company”) (NASDAQ: LULU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The DJS Law Group · Via Business Wire · November 4, 2026
Signet Jewelers Announces Timing of Fiscal 2027 Third Quarter Earnings Release and Conference Call
Signet Jewelers Limited (NYSE: SIG) intends to announce its third quarter results at approximately 7:00 a.m. ET on Wednesday, December 2, 2026.
By Signet Jewelers Limited · Via Business Wire · November 4, 2026
Callodine Group Appoints Todd Marsh as Chief Operating Officer of Its Private Credit Platform
Callodine Group (“Callodine”), an asset management platform focused on yield-oriented investment strategies across public and private markets, today announced the appointment of Todd Marsh as Chief Operating Officer of its Private Credit Platform. In this newly created role, Mr. Marsh will support the continued growth and development of Callodine’s private credit business, bringing extensive experience in operations, technology, fund finance and platform integration.
By Callodine Group · Via Business Wire · November 4, 2026
Madison Square Garden Entertainment Corp. Reports Fiscal 2027 First Quarter Results
Madison Square Garden Entertainment Corp. (NYSE: MSGE) (“MSG Entertainment” or the “Company”) today reported financial results for the fiscal first quarter ended September 30, 2026.
Arrowhead Pharmaceuticals Refinances Existing Credit Facility, Lowering Borrowing Costs and Extending Maturity
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has completed a refinancing with funds managed by Sixth Street that lowers its borrowing costs, improves near-term liquidity, extends its debt maturity, and increases financial and operational flexibility. The transaction retires Arrowhead’s existing $400 million Sixth Street facility at a $68 million discount to the contractual minimum repayment amount and establishes a new $400 million Sixth Street senior secured term loan facility bearing interest at the Secured Overnight Financing Rate (SOFR) plus 5.50%.
By Arrowhead Pharmaceuticals, Inc. · Via Business Wire · November 4, 2026
DISCO Announces Third Quarter 2026 Financial Results
CS Disco, Inc. (“DISCO”) (NYSE: LAW) today announced financial results for its third quarter ended September 30, 2026.
By DISCO · Via Business Wire · November 4, 2026
DISCO Announces Senior Hires to Accelerate AI for Litigators
DISCO (NYSE: LAW), a creator of industry-leading litigation technology, today announced two significant additions to its senior leadership team as it accelerates its strategy to lead in AI for Litigators.
By DISCO · Via Business Wire · November 4, 2026
Blockworks Brings Premier Institutional Event, Digital Asset Summit, Back to London
Blockworks’ flagship event, Digital Asset Summit (DAS) London, arrives in London for its sixth edition, convening the leaders shaping the future of digital assets. Hosted at the London Hilton on Park Lane, the summit will bring together executive voices from leading institutions to examine how evolving market dynamics in digital assets, AI, and breakthrough institutional products are transforming the global financial landscape.
By Blockworks · Via Business Wire · November 4, 2026
The New York Times Company Reports Third-Quarter 2026 Results
The New York Times Company (NYSE: NYT) announced today that its third-quarter 2026 financial results are available on The New York Times Company’s investor relations website at investors.nytco.com.
By The New York Times Company · Via Business Wire · November 4, 2026
Impart Launches Runtime Defense Harness, Bringing 60-Minute AI Virtual Patches to Security Teams
Impart Security, an AI runtime protection platform, today launched the Runtime Defense Harness, a controlled environment where AI agents write and test virtual patches for new vulnerabilities without putting AI in the traffic path. The launch comes as exploits increasingly outpace fixes.
By Impart Security · Via Business Wire · November 4, 2026
CDW Declares Quarterly Cash Dividend of $0.680 Per Share
CDW Corporation (Nasdaq: CDW) announced today that its Board of Directors declared a quarterly cash dividend of $0.680 per common share to be paid on December 10, 2026, to all stockholders of record as of the close of business on November 25, 2026. This amount represents approximately an 8 percent increase over last year's dividend and is aligned with the target of 25 percent of the trailing-twelve-month Non-GAAP net income through September 30, 2026.
By CDW Corporation · Via Business Wire · November 4, 2026
AcuityAI Now Includes Health Network Data to Help MedTech Teams Uncover Opportunities Across Entire Health Systems
AcuityMD, the AI platform for MedTech, today announced the availability of health network intelligence in AcuityAI, giving MedTech commercial teams a comprehensive view of healthcare sites, sales performance, and opportunities across health systems and purchasing networks. Sales teams can ask AcuityAI about integrated delivery networks (IDNs), group purchasing organizations (GPOs), regional purchasing coalitions (RPCs), and management services organizations (MSOs) and get instant responses grounded in AcuityMD’s trusted network data.
By AcuityMD · Via Business Wire · November 4, 2026
Augmodo Appoints Capri Brixey as Head of Retail Sales To Scale AI Shelf Intelligence Across the Physical Workforce
Augmodo, the leader in wearable AI assistants for the physical workforce, today announced the appointment of Capri Brixey as Head of Retail Sales. Brixey will lead Augmodo's retail business, from strategy and revenue through customer success at scale, as the spatial AI company continues expanding beyond retail into suppliers, warehouses, factories, hospitals and more.
By Augmodo · Via Business Wire · November 4, 2026
Kraft Heinz to Divest North America Coffee Business to One Rock Capital Partners
The Kraft Heinz Company (NYSE: KHC) (“Kraft Heinz” or the “Company”) today announced that it has entered into a definitive agreement with an affiliate of One Rock Capital Partners, LLC (together with its affiliates, “One Rock”), to divest its North America coffee business (the “Business”) at an enterprise value of $650 million. Kraft Heinz will retain a 30% non-controlling equity stake in the Business. One Rock is a value-oriented, operationally focused private equity firm with in-depth experience in the food and beverage sector.
By The Kraft Heinz Company · Via Business Wire · November 4, 2026
Kraft Heinz Announces Two New Members to Its Board of Directors
The Kraft Heinz Company (NYSE: KHC) (“Kraft Heinz” or the “Company”) today announced that Kelly Dilts and J. Michael (Mike) Schlotman have been appointed to its Board of Directors (“Board”), effective Nov. 4, 2026.
By The Kraft Heinz Company · Via Business Wire · November 4, 2026
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today reported financial results and recent business updates for the third quarter ended September 30, 2026.
By Viridian Therapeutics, Inc. · Via Business Wire · November 4, 2026
The Kraft Heinz Company Declares Regular Quarterly Dividend of $0.40 Per Share
The Kraft Heinz Company (NYSE: KHC) announced today that the Company’s Board of Directors declared a regular quarterly dividend of $0.40 per share of common stock payable on December 23, 2026, to stockholders of record as of December 4, 2026.
By The Kraft Heinz Company · Via Business Wire · November 4, 2026
Capra Bank and Zact Expand Partnership to Drive Commercial Banking Growth
Capra Bank and Zact, a bank-first commercial banking technology company, today announced the launch of Capra SpendLink, the latest development in their longstanding collaboration to deliver modern financial capabilities to Capra's commercial customers. The launch builds on an established commercial card program powered by Zact that has helped Capra expand its commercial payments business, serve a growing base of corporate customers, and generate new revenue opportunities.
By Zact Inc. · Via Business Wire · November 4, 2026
Frontier Medicines to Present Preclinical Data for FMC-242, a Novel Covalent Allosteric PI3Kα-RAS Breaker, at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Frontier Medicines Corporation (Frontier), a clinical-stage, AI-powered precision medicines company that discovers and develops covalent medicines for previously undruggable and hard-to-drug disease-causing targets, starting with cancer, today announced that it will present preclinical data from its FMC-242 program at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, taking place in Barcelona, Spain, from November 18–20. FMC-242 is a novel, orally bioavailable, covalent allosteric breaker of the PI3Kα-RAS interaction designed using Frontier’s proprietary, AI-powered CovalentAI™ Platform. PI3Kα is the second most frequently mutated oncogene in human cancer and plays an essential role in both PI3Kα and RAS-driven cancers.
By Frontier Medicines Corporation · Via Business Wire · November 4, 2026
Marriott Vacations Worldwide Reports Third Quarter 2026 Financial Results
Marriott Vacations Worldwide Corporation (NYSE: VAC) (“MVW,” the “Company,” “we” or “our”) reported financial results for the third quarter of 2026.
Empower Brands Announces Proposal to Acquire Helen of Troy Ltd. for $37.00 Per Share in Cash
Empower Brands Holdings Group, LLC (“Empower Brands”), the Home & Personal Care business jointly owned by Spectrum Brands Holdings, Inc. (“Spectrum Brands” or “SPB”) (NYSE: SPB) and funds managed by Oaktree Capital Management, L.P. (“Oaktree”), announced it has submitted a non-binding proposal (the “Proposal”) to the Board of Directors of Helen of Troy Limited (“Helen of Troy”, “HELE” or the “Company”) (NASDAQ: HELE) to acquire 100% of the outstanding common equity of Helen of Troy in an all-cash transaction (the “Transaction”) for $37.00 per share at an implied enterprise value of approximately $1.6 billion. An affiliate of Empower Brands currently owns approximately 4.5% of the Company’s outstanding shares, reflecting its conviction in the value and strategic merits of the proposed Transaction.
By Spectrum Brands Holdings, Inc. · Via Business Wire · November 4, 2026
Assured Guaranty Ltd. Declares Quarterly Dividend of $0.38 per Common Share
Assured Guaranty Ltd. (NYSE:AGO) today declared a quarterly dividend of $0.38 per common share. The dividend is payable on December 2, 2026 to shareholders of record at the close of business on November 18, 2026.
By Assured Guaranty Ltd. · Via Business Wire · November 4, 2026
Prolink Partners with Nurses on Boards Coalition to Promote More Nurses into Healthcare Leadership Roles
Prolink, a premier workforce solutions firm, has been selected as a new member organization of the Nurses on Boards Coalition (NOBC), a national coalition that works to improve the health of communities by increasing nurses’ influence on boards and other leadership roles. NOBC set a goal of having 30,000 board seats filled by nurses by 2035. The coalition serves more than 30,000 nurses, along with strategic partners, sponsors, and member organizations with education, placement assistance, mentoring, and developing evidence of the impact of nurses serving on boards.
By Prolink · Via Business Wire · November 4, 2026
AN2 Therapeutics Advances Pipeline With Development Candidate Nomination for Hypophosphatasia (HPP)
AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical-stage biopharmaceutical company discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced the advancement of AN2-504661, a novel boron-based ENPP1 inhibitor, as a development candidate for the treatment of HPP.
By AN2 Therapeutics, Inc. · Via Business Wire · November 4, 2026
Bruker Reports Third Quarter 2026 Financial Results
Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2026.
By Bruker Corporation · Via Business Wire · November 4, 2026
Reynolds Consumer Products Reports Third Quarter 2026 Financial Results
Reynolds Consumer Products Inc. (the “Company”) (Nasdaq: REYN) today reported financial results for the third quarter ended September 30, 2026.
By Reynolds Consumer Products Inc. · Via Business Wire · November 4, 2026
Sapphiros and binx health Combine to Form Onvaro, a Next-Generation Diagnostics Company
Sapphiros, a diagnostics platform backed by investment funds managed by KKR, and binx health, a point-of-care diagnostics company backed by Hildred, a health care-focused private equity firm, today announced that they have combined to form Onvaro, a next-generation diagnostics company built to bring fast, accurate, and affordable testing to the point of need across health care and consumer settings. As part of this combination, investment funds managed by KKR, through its Health Care Strategic Growth strategy, Hildred, and EQT Life Sciences are investing capital to support Onvaro’s growth trajectory.
By KKR & Co. Inc. · Via Business Wire · November 4, 2026